Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1963 May 1;117(5):799-812.
doi: 10.1084/jem.117.5.799.

Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb

Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb

A M SILVERSTEIN et al. J Exp Med. .

Abstract

The fetal lamb in utero is able to form large amounts of specific antibody in response to antigenic stimulus as early as the 66th to 70th day of the 150 day gestation period. Among the several antigens employed, the fetal lamb responded earliest, and with the highest titers, to bacteriophage varphiX. Slightly less effective as an antigen was horse ferritin, while ovalbumin proved to be a weak antigen, especially in younger fetuses. Ineffective in stimulating an antibody response at any time during fetal or early neonatal life were diphtheria toxoid, Salmonella typhosa, and BCG. Thus, it may not be feasible to fix precisely the time of onset of immunologic responsiveness in a species, inasmuch as it appears to differ so greatly from one antigen to another. The quantity of antibody found 10 days after varphiX immunization was not significantly different in fetuses injected at 60 to 120 days of gestation. The earliest anti-phage antibody produced by the lamb fetus is a macroglobulin sensitive to the action of 2-mercaptoethanol. Only in older fetuses with longer lasting stimuli were appreciable amounts of 7S gamma-globulin antibodies formed. The conformity of these observations to theories on the ontogenesis of the immune response is discussed.

PubMed Disclaimer

References

    1. J Clin Invest. 1962 Jul;41:1509-13 - PubMed
    1. J Lab Clin Med. 1950 Feb;35(2):303-7 - PubMed
    1. J Exp Med. 1962 Mar 1;115:655-70 - PubMed
    1. Aust J Biol Sci. 1953 Aug;6(3):533-46 - PubMed
    1. Nature. 1960 Sep 24;187:1130-1 - PubMed